Ms. Michelle Lefler reports

AURORA INTRODUCES INNOVATIVE CANNABIS OIL RANGE TO MEET DIVERSE PATIENT NEEDS IN AUSTRALIA

Aurora Cannabis Inc., in conjunction with MedReleaf Australia, will offer an enhanced product range of premium medical cannabis oil in Australia. This expansion reinforces Aurora's dedication to providing high-quality, innovative cannabis solutions to patients around the world. Now available for physicians to prescribe, the new cannabis oils include a variety of cannabinoid ratios to suit diverse patient needs.

The newly launched cannabis oil products include Aurora THC 25 (sativa) in a 30-millilitre bottle, Aurora THC 25 (indica) in a 30-millilitre bottle, Aurora 12.5:12.5 oil in a 30-millilitre bottle, Aurora 50:50 oil in a 30-millilitre bottle and Aurora 10:100 oil in a 30-millilitre bottle. Each formulation offers varying cannabinoid ratios to support personalized treatment options for patients.

"We are thrilled to bring this enhanced range of cannabis oil products to the Australian market," said Andre Jerome, executive vice-president, global business development, at Aurora. "Our mission is to offer healthcare providers and their patients a broader selection of treatment options that meet their various medical needs. By expanding our product portfolio, we continue to demonstrate our commitment to advancing patient care through high-quality, science-driven cannabis solutions."

The newly available oils are developed and manufactured at Aurora's Canadian TGA and EU GMP certified facility, add to the expanding lineup with increased cannabinoid variety. The new products allow Doctors to tailor treatments more precisely, enhancing patient care. These offerings are another step forward in MedReleaf Australia's mission to expand access to quality medical cannabis options for patients across the country.

Key features of Aurora's new cannabis oil products include:

• Comprehensive cannabinoid profiles: Designed to provide targeted and effective relief with a variety of THC (tetrahydrocannabinol) and CBD (cannabidiol) ratios;
• High standards of quality and safety: Manufactured in TGA-GMP certified facilities, adhering to rigorous quality control measures;
• Broad selection: Wide range of unique oil formulations, allowing for customized patient care.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co.; as well as international brands Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

Aurora's common shares trade on the Nasdaq Stock Market and the Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.